TRAFALIS DIMITRIOS

PhD in Medicine, National and Kapodistrian University of Athens
Professor of Pharmacology and Clinical Pharmacology
Director of the A' Medical Oncology Unit, Cosmoclinic Diagnostic and Medical Center

Clinical Pharmacology
Professional Experience
Clinical experience in Therapeutic Oncology, 20 years
Lecturer at the Medical School of Athens in undergraduate and postgraduate programs, 2009 – Present
Head of the Cancer Therapeutics Unit at the Medical School of the National and Kapodistrian University of Athens – elected faculty member (DEP), 2008 – Present
Regular member and chair of several scientific committees for the approval of treatments, indications, and registration of new pharmaceutical products
Scientific reviewer of clinical protocols and studies at the National Organization for Medicines (EOF)
Supervising professor for more than six doctoral theses (PhDs) and member of advisory committees for many others
Medical Director and Product Director in the pharmaceutical industry
Consulting advisor on technical and regulatory affairs in the pharmaceutical industry

BSc in Biology, University of Patras
Medical Degree (MD), National and Kapodistrian University of Athens
Master of Philosophy (MPhil) in Biosciences, University of Canterbury, United Kingdom
Postgraduate Diploma in Radiobiology and Cytogenetics, NCSR “Demokritos”
PhD in Pharmaceutical Chemistry and Pharmacology, Department of Pharmacy, University of Patras / NCSR “Demokritos”

Medical Oncology, 2006

Author of more than 140 research papers in high-impact international peer-reviewed journals and presentations at more than 150 international and national scientific conferences
His published research has been cited more than 4,000 times in other scientific publications (H-Index = 28)
Part of his research has been incorporated into two internationally granted patents (sole inventor) concerning new anticancer drugs

Research activity as a postgraduate researcher, postdoctoral researcher, and professor in Greece and abroad, focusing on Cancer Therapeutics, the implementation of advanced and innovative therapeutic protocols, Experimental Pharmacology, and Clinical Pharmacology
Certified by the European Medicines Agency (EMA) in Pharmacovigilance
Certified in GCP (Good Clinical Practice) and GCLP (Good Clinical Laboratory Practice) by international health organizations
More than 30 years of research focused on drug design and development
Director of the preparation process for the submission of four upcoming international patents related to cancer therapy
Participation as a speaker or presenter of original research in more than 150 international scientific conferences
Organizer of more than 10 international and national oncology scientific conferences and meetings

ONCOLOGIST